Protocols
Glioma (Adjuvant)
CNAJ12TZRT
Concomitant (Dual Modality) and 12 Cycles of Adjuvant Temozolomide for Newly Diagnosed Malignant Gliomas with Radiation
CNAJTZRT
Concomitant (Dual Modality) and Adjuvant Temozolomide for Newly Diagnosed Malignant Gliomas with Radiation
CNELTZRT
Treatment of Elderly Newly Diagnosed Glioma Patient with Concurrent and Adjuvant Temozolomide and Radiation Therapy
Glioma (Advanced)
CNBEV
Palliative Therapy for Recurrent Malignant Gliomas Using Bevacizumab With or Without Concurrent Etoposide or Lomustine
CNCARV
CARBOplatin and Etoposide in the Treatment of Recurrent Ependymoma
CNCCNU
Lomustine (CCNU) for Treatment of Recurrent Malignant Brain Tumours
CNETO
Palliative Treatment of Patients with Recurrent Malignant Gliomas and Ependymoma Using Low Dose Etoposide
CNMODPCV
Modified PCV Chemotherapy of Brain Tumours Using Procarbazine, Lomustine (CCNU) and vinCRIstine
CNPROC
Standard Procarbazine for Second Line Treatment of Recurrent Brain Tumour
CNTEM60
Therapy for Newly Diagnosed Malignant Brain Tumours with MGMT Methylation in Elderly Patients using Temozolomide
CNTEMOZ
Therapy for Malignant Brain Tumours Using Temozolomide
CNTEMOZMD
Therapy for Malignant Brain Tumours using Metronomic Dosing of Temozolomide
Therapy for Recurrent Malignant Brain Tumours using Temozolomide and Etoposide
Primary Neuroectodermal Tumours (PNET)
CNCCV
Adjuvant lomustine, CISplatin and vinCRIstine in Adult High-Risk Medulloblastoma or Other Primitive Neuroectodermal Tumour
CNMODPCV
Modified PCV Chemotherapy of Brain Tumours Using Procarbazine, Lomustine (CCNU) and vinCRIstine
Pituitary
CNB
Therapy for Pituitary Adenomas Using Bromocriptine
CNCAB
Therapy for Pituitary Adenomas Using Cabergoline
Treatment of Growth Hormone Secreting Pituitary Adenoma Using Lanreotide (SOMATULINE AUTOGEL®)
CNOCTLAR
Treatment of Growth Hormone Secreting Pituitary Adenoma Using Octreotide
CNQUIN
(deleted 01 Feb 2022)
Therapy for Pituitary Adenomas Using Quinagolide
Top
Others
Therapy for Advanced Solitary Fibrous Tumours and Hemangiopericytoma Using Temozolomide and Bevacizumab